Filing Details

Accession Number:
0001415889-21-002686
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-26 17:24:18
Reporting Period:
2021-05-24
Accepted Time:
2021-05-26 17:24:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
856982 Merit Medical Systems Inc MMSI Surgical & Medical Instruments & Apparatus (3841) 870447695
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1742555 Jr. Raul Parra 1600 West Merit Parkway
South Jordan UT 84095
Cfo And Treasurer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2021-05-24 1,000 $16.05 3,343 No 4 M Direct
Common Stock, No Par Value Acquisiton 2021-05-24 1,000 $17.27 4,343 No 4 M Direct
Common Stock, No Par Value Disposition 2021-05-24 2,000 $63.16 2,343 No 4 S Direct
Common Stock, No Par Value Acquisiton 2021-05-25 1,000 $16.05 3,343 No 4 M Direct
Common Stock, No Par Value Acquisiton 2021-05-25 4,000 $28.20 7,343 No 4 M Direct
Common Stock, No Par Value Disposition 2021-05-25 5,000 $63.76 2,343 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock options (right to buy) Disposition 2021-05-24 1,000 $0.00 1,000 $17.27
Common Stock Non-qualified stock options (right to buy) Disposition 2021-05-24 1,000 $0.00 1,000 $16.05
Common Stock Non-qualified stock options (right to buy) Disposition 2021-05-25 4,000 $0.00 4,000 $28.20
Common Stock Non-qualified stock options (right to buy) Disposition 2021-05-25 1,000 $0.00 1,000 $16.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-02-13 2022-02-13 No 4 M Direct
1,000 2017-01-28 2023-01-28 No 4 M Direct
2,000 2018-04-14 2024-04-14 No 4 M Direct
0 2017-01-28 2023-01-28 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, No Par Value 2,906 Indirect By 401(k) Plan
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-qualified stock options (right to buy) $44.80 2019-03-02 2025-03-02 8,000 8,000 Direct
Common Stock Non-qualified stock options (right to buy) $55.73 2020-03-01 2026-03-01 30,000 30,000 Direct
Common Stock Non-qualified stock options (right to buy) $37.71 2021-02-26 2027-02-26 16,722 16,722 Direct
Common Stock Non-qualified stock options (right to buy) $56.25 2022-03-19 2028-03-19 9,681 9,681 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-03-02 8,000 8,000 Direct
2026-03-01 30,000 30,000 Direct
2027-02-26 16,722 16,722 Direct
2028-03-19 9,681 9,681 Direct
Footnotes
  1. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.75 to $63.87, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  2. Represents plan holdings as of 05/26/2021.
  3. Becomes exercisable in equal annual installments of 20% commencing 02/03/2016.
  4. Becomes exercisable in equal annual installments of 20% commencing 01/28/2017.
  5. Becomes exercisable in equal annual installments of 20% commencing 04/14/2018.
  6. Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.
  7. Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.
  8. Becomes exercisable in equal annual installments of 25% commencing 02/26/2021. Prior reports incorrectly listed 02/26/2020 as the date exercisable.
  9. Becomes exercisable in equal annual installments of 25% commencing 03/19/2022.